Fig. 2From: The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010A. OS curves according to pathological stage. 5-year OS rates were 92.9% in patients with stage IA, 85.3% in stage IB, 70.9% in p stage IIA, 64.4% in stage IIB and 59.8% in stage IIIA. B. OS curves according to predominant histological subtype. The 5-year OS rates was 94.4% in patients with AIS. 94.0% in MIA, 90.2% in lepidic, 86.7% in variants, 84.1% in papillary, 80.4% in acinar, 78.0% in micropapillary and 65.4% in solid. C. OS curves according to histological groups in pathological stage I. The 5-year OS rates was 95.8% in patients with group A, 92.1% in group B, 89.7% in group C and 79.0% in group D. D. OS curves according to histological groups in pathological stage II + III. The 5-year OS rates was 72.4% in patients with group B, 66.9% in group C and 53.7% in group DBack to article page